Prosight Management »

Emergent BioSolutions shares owned by Prosight Management

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Prosight Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.3M 639k 8.30

More positions owned by Prosight Management

Nektar Therapeutics Com New (NKTR)
Boston Scientific Corporation (BSX)
Janux Therapeutics (JANX)
Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr
Genedx Holdings Corp Com Cl A (WGS)
Shattuck Labs (STTK)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Alnylam Pharmaceuticals (ALNY)
Meiragtx Holdings (MGTX)
Alkermes SHS (ALKS)
Syndax Pharmaceuticals (SNDX)
Veeva Sys Cl A Com (VEEV)
Zymeworks Del (ZYME)

View all positions for Prosight Management

Top funds holding Emergent BioSolutions

BlackRock
State Street Corporation
Dimensional Fund Advisors
American Century Companies
Vanguard Capital Management
Charles Schwab Investment Management
Acadian Asset Management
Geode Capital Management
Palisade Capital Management
Vanguard Portfolio Management
Oak Hill Advisors
D. E. Shaw & Co
AQR Capital Management
LSV Asset Management
Goldman Sachs Group

View all funds holding Emergent BioSolutions